Cost-effectiveness of hydroxyurea for children with sickle cell disease in sub-saharan Africa: A discrete event simulation model to inform policy and government planning

Research
Written By Christine Briscoe

Authors: Patrick McGann, Donald Ayers, Lydia Musula, Paul Niklewski

Published: November 3, 2025

Click Here to Read More
Christine Briscoe
Previous

Describing the feasibility and acceptability of an electronic adherence monitor to measure hydroxyurea adherence among youth with sickle cell disease
Next

Baseline data from the prioritizing utilization and safety of hydroxyurea using precision in Africa (PUSHUP) trial